Annual accounts receivable:
$46.76M+$30.14M(+181.33%)Summary
- As of today (May 23, 2025), TARS annual accounts receivable is $46.76 million, with the most recent change of +$30.14 million (+181.33%) on December 31, 2024.
- TARS annual accounts receivable is now at all-time high.
Performance
TARS Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$62.43M+$15.67M(+33.50%)Summary
- As of today (May 23, 2025), TARS quarterly accounts receivable is $62.43 million, with the most recent change of +$15.67 million (+33.50%) on March 31, 2025.
- Over the past year, TARS quarterly accounts receivable has increased by +$32.54 million (+108.89%).
- TARS quarterly accounts receivable is now at all-time high.
Performance
TARS Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
TARS Accounts receivable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +181.3% | +108.9% |
3 y3 years | - | +10000.0% |
5 y5 years | - | - |
TARS Accounts receivable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | >+9999.0% | at high | >+9999.0% |
5 y | 5-year | at high | >+9999.0% | at high | >+9999.0% |
alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
TARS Accounts receivable History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $62.43M(+33.5%) |
Dec 2024 | $46.76M(+181.3%) | $46.76M(+60.4%) |
Sep 2024 | - | $29.16M(-1.3%) |
Jun 2024 | - | $29.53M(-1.2%) |
Mar 2024 | - | $29.89M(+79.8%) |
Dec 2023 | $16.62M | $16.62M(+210.0%) |
Sep 2023 | - | $5.36M(+114.5%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2023 | - | $2.50M(>+9900.0%) |
Dec 2022 | $0.00 | $0.00(-100.0%) |
Sep 2022 | - | $17.00K(0.0%) |
Jun 2022 | - | $17.00K(0.0%) |
Mar 2022 | - | $17.00K(-99.9%) |
Jun 2021 | - | $20.00M(-20.0%) |
Mar 2021 | - | $25.00M |
FAQ
- What is Tarsus Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual accounts receivable year-on-year change?
- What is Tarsus Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Tarsus Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of TARS is $46.76M
What is the all time high annual accounts receivable for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual accounts receivable is $46.76M
What is Tarsus Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, TARS annual accounts receivable has changed by +$30.14M (+181.33%)
What is Tarsus Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of TARS is $62.43M
What is the all time high quarterly accounts receivable for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly accounts receivable is $62.43M
What is Tarsus Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, TARS quarterly accounts receivable has changed by +$32.54M (+108.89%)